EUVIMEDEUVIMED entdecken
Crossref

Therapeutic potential of plant-derived bioactive polyphenols in chronic disease management: A review of molecular mechanisms and translational evidence from preclinical to clinical pathology

Mohammad Saidurrahman, Mohd Aftab Siddiqui, Mirunalini Gobinath, Afreen Usmani

Comparative Clinical Pathology · 16.11.2026 · 35 (1)

DOI: 10.1007/s00580-026-03885-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Comparative Clinical Pathology, online erschienen am 16.11.2026. Verfasst von Mohammad Saidurrahman und 3 weiteren Autor:innen. Die Arbeit nennt 216 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interest in bioactive polyphenols derived from plants as potential therapeutic agents for preventing and managing chronic diseases is increasingly being investigated. Polyphenols have a wide range of activities, including antioxidant, anti-inflammatory, antidiabetic, cardioprotective, neuroprotective, and anticancer effects. These properties are mediated by the modulation of several molecular targets and signaling pathways, such as nuclear factor-kappa B (NF-κB), nuclear factor erythroid 2-related factor 2 (Nrf2), AMP-activated protein kinase (AMPK), sirtuin 1 (SIRT1), phosphoinositide 3-kinase/protein kinase B (PI3K/Akt), mitogen-activated protein kinase (MAPK), and signal transducer and activator of transcription 3 (STAT3). This review explores the molecular mechanisms responsible for the therapeutic effects of major polyphenols and the evidence from preclinical studies to clinical investigations. Polyphenols have therapeutic benefits in cardiovascular diseases, diabetes mellitus, metabolic syndrome, neurodegenerative diseases, and cancer. Moreover, the clinical application is limited due to poor aqueous solubility, low oral bioavailability, high first-pass metabolism, chemical instability, and interindividual variability in therapeutic response. Nanotechnology-based delivery systems such as liposomes, polymeric nanoparticles, nanostructured lipid carriers, and exosome-based nano system are novel strategies that can be used to overcome these challenges. New ideas on interactions with the gut microbiome, microbial metabolite effects, epigenetic control, nutrigenomics, and precision nutrition continue the expansion of the therapeutic possibilities of polyphenol research. In general, polyphenols are an interesting group of bioactive molecules for chronic disease management; however, further clinical studies, optimization of their formulations, and development of targeted therapeutic strategies need to be undertaken to ensure their successful translation from bench to bedside. Graphical Abstract Major biological activities of polyphenols:- Anti-cancer activity (DNA damage regulation, ROS modulation, antioxidant, anti-inflammatory, and anti-proliferative effects); Anti-diabetic activity (targeting insulin resistance, insulin sensitivity, fasting blood glucose, HbA1c, HOMA-β, anti-inflammatory and ROS regulation); Anti-obesity activity (regulation of LDL and metabolic parameters); Immunomodulatory activity (modulation of natural killer cells, macrophages, anti-inflammatory pathways, antioxidants, ROS and immune responses to viral infections); Antimicrobial activity (antibacterial, antiviral, and antifungal); Neuroprotective and cardioprotective activities (ROS reduction and anti-inflammatory effects); and Anti-arthritic activity (antioxidant, anti-inflammatory effects and ROS regulation).

Zitieren

APA

Saidurrahman, M., Siddiqui, M. A., Gobinath, M., & Usmani, A. (2026). Therapeutic potential of plant-derived bioactive polyphenols in chronic disease management: A review of molecular mechanisms and translational evidence from preclinical to clinical pathology. Comparative Clinical Pathology, 35(1). https://doi.org/10.1007/s00580-026-03885-w

Vancouver

Saidurrahman M, Siddiqui MA, Gobinath M, Usmani A. Therapeutic potential of plant-derived bioactive polyphenols in chronic disease management: A review of molecular mechanisms and translational evidence from preclinical to clinical pathology. Comparative Clinical Pathology. 2026;35(1). doi:10.1007/s00580-026-03885-w

BibTeX
@article{Saidurrahman2026,
  author = {Saidurrahman, Mohammad and Siddiqui, Mohd Aftab and Gobinath, Mirunalini and Usmani, Afreen},
  title = {Therapeutic potential of plant-derived bioactive polyphenols in chronic disease management: A review of molecular mechanisms and translational evidence from preclinical to clinical pathology},
  journal = {Comparative Clinical Pathology},
  year = {2026},
  volume = {35},
  number = {1},
  doi = {10.1007/s00580-026-03885-w}
}
Kostenlos starten →